Study offers hope for Africa's next generation.
D000284:Administration, Oral; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D001942:Breast Feeding / Q000009:adverse effects; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D005260:Female; D015658:HIV Infections / Q000191:economics / Q000635:transmission*; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D007391:International Cooperation; D019829:Nevirapine / Q000008:administration & dosage*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control*; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage*; D014454:Uganda; D014481:United States
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine